New York State Common Retirement Fund Mei Pharma, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.42 - $0.65 $22,459 - $34,759	-53,476 Reduced 98.29%	933 $1,000
Q1 2022 May 05, 2022	BUY	$0.54 - $2.74 $17 - $90	33 Added 0.06%	54,409 $33,000
Q4 2021 Feb 02, 2022	SELL	$2.33 - $3.37 $361 - $522	-155 Reduced 0.28%	54,376 $145,000
Q3 2021 Nov 02, 2021	SELL	$2.52 - $2.99 $95,749 - $113,608	-37,996 Reduced 41.06%	54,531 $151,000
Q2 2021 Aug 02, 2021	BUY	$2.6 - $3.65 $2,389 - $3,354	919 Added 1.0%	92,527 $264,000
Q2 2020 Aug 07, 2020	BUY	$1.45 - $4.3 $74,095 - $219,730	51,100 Added 126.15%	91,608 $378,000
Q4 2019 Feb 05, 2020	SELL	$1.65 - $2.48 $41,208 - $61,938	-24,975 Reduced 38.14%	40,508 $100,000
Q3 2019 Nov 07, 2019	SELL	$1.48 - $2.52 $6,833 - $11,634	-4,617 Reduced 6.59%	65,483 $110,000
Q2 2019 Aug 09, 2019	BUY	$2.45 - $3.32 $171,745 - $232,732	70,100 New	70,100 $175,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.